| Influenza and congenital anomalies: a systematic review and meta-analysis JM Luteijn, MJ Brown, H Dolk Human reproduction 29 (4), 809-823, 2014 | 197 | 2014 |
| Maternal influenza and birth outcomes: systematic review of comparative studies DB Fell, DA Savitz, MS Kramer, BD Gessner, MA Katz, M Knight, ... BJOG: An International Journal of Obstetrics & Gynaecology 124 (1), 48-59, 2017 | 158 | 2017 |
| State of the art in benefit–risk analysis: Consumer perception Ø Ueland, H Gunnlaugsdottir, F Holm, N Kalogeras, O Leino, JM Luteijn, ... Food and Chemical Toxicology 50 (1), 67-76, 2012 | 122 | 2012 |
| Influenza epidemiology and immunization during pregnancy: final report of a World Health Organization working group DB Fell, E Azziz-Baumgartner, MG Baker, M Batra, J Beauté, P Beutels, ... Vaccine 35 (43), 5738-5750, 2017 | 93 | 2017 |
| Diagnostic accuracy of culture-based and PCR-based detection tests for methicillin-resistant Staphylococcus aureus: a meta-analysis JM Luteijn, GAA Hubben, P Pechlivanoglou, MJ Bonten, MJ Postma Clinical microbiology and infection 17 (2), 146-154, 2011 | 86 | 2011 |
| State of the art in benefit–risk analysis: food and nutrition MJ Tijhuis, N De Jong, MV Pohjola, H Gunnlaugsdóttir, M Hendriksen, ... Food and Chemical Toxicology 50 (1), 5-25, 2012 | 84 | 2012 |
| Selective serotonin reuptake inhibitor (SSRI) antidepressants in pregnancy and congenital anomalies: analysis of linked databases in Wales, Norway and Funen, Denmark S Jordan, JK Morris, GI Davies, D Tucker, DS Thayer, JM Luteijn, ... PLoS One 11 (12), e0165122, 2016 | 60 | 2016 |
| Modelling the costs and effects of selective and universal hospital admission screening for methicillin-resistant Staphylococcus aureus G Hubben, M Bootsma, M Luteijn, D Glynn, D Bishai, M Bonten, M Postma PloS one 6 (3), e14783, 2011 | 58 | 2011 |
| Costs and consequences of additional chest x-ray in a tuberculosis prevention program in Botswana T Samandari, D Bishai, M Luteijn, B Mosimaneotsile, O Motsamai, ... American journal of respiratory and critical care medicine 183 (8), 1103-1111, 2011 | 51 | 2011 |
| State of the art in benefit–risk analysis: food microbiology SH Magnússon, H Gunnlaugsdóttir, H Van Loveren, F Holm, N Kalogeras, ... Food and chemical toxicology 50 (1), 33-39, 2012 | 40 | 2012 |
| State of the art in benefit–risk analysis: Introduction H Verhagen, MJ Tijhuis, H Gunnlaugsdόttir, N Kalogeras, O Leino, ... Food and Chemical Toxicology 50 (1), 2-4, 2012 | 33 | 2012 |
| Looking beyond borders: Integrating best practices in benefit–risk analysis into the field of Food and Nutrition MJ Tijhuis, MV Pohjola, H Gunnlaugsdottir, N Kalogeras, O Leino, ... Food and chemical toxicology 50 (1), 77-93, 2012 | 30 | 2012 |
| State of the art in benefit–risk analysis: environmental health MV Pohjola, O Leino, V Kollanus, JT Tuomisto, H Gunnlaugsdóttir, F Holm, ... Food and chemical toxicology 50 (1), 40-55, 2012 | 29 | 2012 |
| State of the art in benefit–risk analysis: Medicines JM Luteijn, BC White, H Gunnlaugsdóttir, F Holm, N Kalogeras, O Leino, ... Food and chemical toxicology 50 (1), 26-32, 2012 | 26 | 2012 |
| Differences in pandemic influenza vaccination policies for pregnant women in Europe JM Luteijn, H Dolk, GJ Marnoch BMC Public Health 11, 1-9, 2011 | 26 | 2011 |
| Cost–benefit analysis of the polypill in the primary prevention of myocardial infarction and stroke NJ Wald, JM Luteijn, JK Morris, D Taylor, P Oppenheimer European journal of epidemiology 31, 415-426, 2016 | 25 | 2016 |
| Implementation of the harmonized EU isotretinoin Pregnancy Prevention Programme: a questionnaire survey among European regulatory agencies I Crijns, S Straus, M Luteijn, CG Wied, J Raine, LJ de Berg Drug safety 35, 27-32, 2012 | 25 | 2012 |
| A model framework for projecting the prevalence and impact of Long-COVID in the UK C Martin, M Luteijn, W Letton, J Robertson, S McDonald PLoS One 16 (12), e0260843, 2021 | 23 | 2021 |
| WHO taskforce to evaluate influenza data to inform vaccine impact and economic modelling. Influenza epidemiology and immunization during pregnancy: final report of a World … DB Fell, E Azziz-Baumgartner, MG Baker, M Batra, J Beauté, P Beutels, ... Vaccine 35 (43), 5738-50, 2017 | 22 | 2017 |
| EUROmediCAT signal detection: an evaluation of selected congenital anomaly‐medication associations JE Given, M Loane, JM Luteijn, JK Morris, LTW de Jong van den Berg, ... British journal of clinical pharmacology 82 (4), 1094-1109, 2016 | 21 | 2016 |
